Journalartikel

Jahr der Veröffentlichung: 2016

Seiten: 539-548

Zeitschrift: Urologe A

Bandnummer: 55

Heftnummer: 4

ISSN: 0340-2592

eISSN: 1433-0563

DOI Link: https://doi.org/10.1007/s00120-016-0072-y

Verlag: Springer

Abstract: 
Hormone replacement therapy with testosterone has become well-established over the course of time. The initial substantial concerns with respect to complications and potential adverse events, particularly in older patients, were proven to be unfounded over time. Testosterone therapy has therefore gradually become a regular treatment modality in urological practice. It has also been shown to represent a valuable tool as supportive treatment for patients with erectile dysfunction and hypogonadism. A variety of testosterone preparations are available for treatment. Recent pharmaceutical developments have greatly improved the practicability and ease of administration for patients. Several guidelines have been developed that provide clearly formulated standards and instructions for indications, contraindications, application, risk factors and monitoring of testosterone therapy. Adverse events affecting the cardiovascular system and especially diseases of the prostate gland are of great importance, thus making the urologist the primary partner in the treatment of patients with testosterone deficiency.

Harvard-Zitierstil: Diemer, T., Hauptmann, A. and Wagenlehner, F. (2016) Testosterone therapy, Urologe A, 55(4), pp. 539-548. https://doi.org/10.1007/s00120-016-0072-y

APA-Zitierstil: Diemer, T., Hauptmann, A., & Wagenlehner, F. (2016). Testosterone therapy. Urologe A. 55(4), 539-548. https://doi.org/10.1007/s00120-016-0072-y